OR WAIT 15 SECS
Parexel International is enhancing its early-phase cardiac safety capabilities through a new alliance with Mortara Instrument, a worldwide manufacturer and distributor of ECG devices and related technology based in Milwaukee, WI. Specifically, Parexel will supplement its ECG equipment with Mortara Instrument's Surveyor Telemetry Central System, which is already in use at the company's Baltimore, MD, early phase clinical unit.
"This relationship represents our commitment to providing comprehensive early phase cardiovascular expertise and capabilities, such as intensive ECG and thorough QT/QTc studies, supported by enabling technologies,” said Michelle Middle, Parexel's corporate VP and worldwide head of early phase, in a company press release.
Mortara's high-tech solution will automate the process of acquiring and recording ECGs for Parexel, which are wirelessly transmitted from devices worn by clinical trial participants.